Synaptive completes sale of all of its shares to a group of strategic investors

Torys acted as counsel to Synaptive with a team led by Adam Slavens and including Mike Noel (restructuring), Kendall Grant (corporate/M&A), Omar Wakil (competition), Tom Stevenson and Parker Baglole (employment), John Tobin and Julia Zhuo (tax).

On June 26, 2025, Synaptive Medical Inc. (“Synaptive”) announced the completion of the sale of all of its shares to a group of strategic investors (the “Purchaser”).

On March 19, 2025, Synaptive sought and obtained an order from the Ontario Superior Court of Justice (Commercial List) for creditor protection under the Companies' Creditors Arrangement Act (Canada) (the “CCAA”). The transaction was a part of a court-supervised sale and investment solicitation process (the “SISP”) announced on March 26, 2025. Richter Inc. was appointed as monitor during the proceedings.

Synaptive entered into a subscription agreement with the Purchaser (the “Subscription Agreement”), which was declared the winning bid in the SISP. Under the Subscription Agreement, the Purchaser ultimately agreed to acquire all of the shares of Synaptive for total cash consideration of approximately C$9.6 million and an additional amount for working capital. The total consideration ultimately paid by the Purchaser was approximately US$15 million.

The successful completion of the transaction concluded Synaptive’s court-approved SISP. The acquisition marks a significant milestone for Synaptive and the advancement of its neurosurgery platform. The strategic acquisition is expected to reignite Synaptive’s operations so that it can continue developing cutting-edge neurosurgery solutions that save lives and improve surgical outcomes.

Further information can be found on Business Wire’s website.

Synaptive Medical is a Toronto-based global medical technology company dedicated to solving complex challenges in surgery, imaging, and data integration to improve patient outcomes. Its integrated suite of solutions—spanning MRI, surgical planning, navigation, and robotic visualization—delivers intelligent, patient-centric technology that enhances clinical decision-making and efficiency across every stage of neurosurgical care.